Carl R. Walkley
- Hematology top 0.5%
- Acute Myeloid Leukemia Research 21
- Hematopoietic Stem Cell Transplantation 13
- Immunology top 1%
- interferon and immune responses 13
- Molecular Biology top 1%
- RNA regulation and disease 32
- RNA Research and Splicing 31
- RNA modifications and cancer 10
- Genetics top 1%
- Cancer Research top 2%
-
- Sarcoma Diagnosis and Treatment 11
-
- Erythrocyte Function and Pathophysiology 9
- Co-authors
- Louise E. PurtonStuart H. OrkinJin Billy LiJochen C. HartnerAlistair M. ChalkBrian LiddicoatGrant A. McArthurAnthony J. Mutsaers
- Partner nations
- AustraliaUnited StatesSweden
In The Last Decade
Carl R. Walkley
108 papers receiving 7.2k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Hematology 1.5k
- Immunology 1.7k
- Molecular Biology 5.0k
- Genetics 748
- Cancer Research 946
Countries citing papers authored by Carl R. Walkley
This map shows the geographic impact of Carl R. Walkley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl R. Walkley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl R. Walkley more than expected).
Fields of papers citing papers by Carl R. Walkley
This network shows the impact of papers produced by Carl R. Walkley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl R. Walkley. The network helps show where Carl R. Walkley may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carl R. Walkley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 4 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 1 | |
| 5 | ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosisbreakdown → | 2022 | 262 |
| 6 | 2020 | 40 | |
| 7 | 2020 | 26 | |
| 8 | 2019 | 25 | |
| 9 | 2019 | 77 | |
| 10 | 2015 | 54 | |
| 11 | 2014 | 34 | |
| 12 | 2014 | 1 | |
| 13 | 2014 | 1 | |
| 14 | 2013 | 61 | |
| 15 | 2011 | 111 | |
| 16 | 2011 | 20 | |
| 17 | 2010 | 22 | |
| 18 | 2008 | 284 | |
| 19 | 2008 | 15 | |
| 20 | 2006 | 1 |
About Carl R. Walkley
Carl R. Walkley is a scholar working on Hematology, Molecular Biology and Immunology, having authored 110 papers that have together received 7.3k indexed citations. Recurring topics across this work include RNA regulation and disease (32 papers), RNA Research and Splicing (31 papers), Acute Myeloid Leukemia Research (21 papers), interferon and immune responses (13 papers), Hematopoietic Stem Cell Transplantation (13 papers), Sarcoma Diagnosis and Treatment (11 papers), RNA modifications and cancer (10 papers) and Erythrocyte Function and Pathophysiology (9 papers). The work is most often cited by research in Hematology (1.5k citations), Immunology (1.7k citations) and Molecular Biology (5.0k citations). Carl R. Walkley has collaborated with scholars based in Australia, United States and Sweden. Frequent co-authors include Louise E. Purton, Stuart H. Orkin, Jin Billy Li, Jochen C. Hartner, Alistair M. Chalk, Stuart H. Orkin, Brian Liddicoat, Grant A. McArthur, Anthony J. Mutsaers and Jun Lü. Their work appears in journals such as Experimental Hematology, Blood, Bone, Scientific Reports and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.